Share

Zynerba Pharmaceuticals Inc. - news published 160 - readings 4.092

BACK
Zynerba Pharmaceuticals Inc.

Zynerba Pharmaceuticals Inc.

Post-Effective Amendment to Registration Statement - Form POS AM

As filed with the Securities and Exchange Commission on October 11, 2023 No. 333-264966 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT No. 333-264966 UNDER THE SECURITIES ACT OF 1933 Zynerba Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or O ...

Continue reading
11.10.2023
Zynerba Pharmaceuticals Inc.

Zynerba Pharmaceuticals Inc.

Post-effective Amendment to Registration Statement for Employee Benefit Plan - Form S-8 POS

As filed with the Securities and Exchange Commission on October 11, 2023 No. 333-272805 No. 333-270891 No. 333-263128 No. 333-256028 No. 333-237051 No. 333-230182 No. 333-223597 No. 333-216967 No. 333-216968 No. 333-207973 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT No. 333-272805 Pos ...

Continue reading
11.10.2023